PerkinElmer, Inc. (NYSE:PKI)
A provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, academic research, environmental testing and general industrial markets, commonly referred to as the health sciences and photonics markets.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Serial underperformer. No clear strategy combined with confused communication. Can cut costs with the best of them and squeeze out margin improvements but can't grow the top line.
Recs
Looks very cheap. Plus a small dividend.
Recs
Recs
well run company... pharma boom coming...
Recs
Low relative PE, good star ranking, PEG & 09 PE still below normal - bottom fishing 4/27 picks.
Recs
cause my wife is smarter than me
Recs
Restructuring should pay off.
Recs
my 1997 investment up 1.88x to 10/06
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 8 of 8